Gene expression signature for the prediction of FOLFIRI response in advanced colorectal cancer patients

被引：0
|
作者：
Del Rio, Maguy
Molina, Franck
Bascoul-Mollevi, Caroline
Copois, Virginie
Bibeau, Frederic
Chalbos, Patrick
Bareil, Corinne
Kramar, Andrew
Salvetat, Nicolas
Fraslon, Caroline
Conseiller, Emmanuel
Granci, Virginie
Leblanc, Benjamin
Pau, Bernard
Martineau, Pierre
Ychou, Marc
机构：
[1] CNRS, Montpellier, France
[2] CRLC Val Aurelle, Montpellier, France
[3] Sanofi Aventis, Vitry Sur Seine, France
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1294
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Colorectal cancer classification based on gene expression is not associated with FOLFIRI response
    Martinez-Garcia, Raquel
    Lopez-Casas, Pedro P.
    Rico, Daniel
    Valencia, Alfonso
    Hidalgo, Manuel
    NATURE MEDICINE, 2014, 20 (11) : 1230 - 1231
  • [2] Colorectal cancer classification based on gene expression is not associated with FOLFIRI response
    Raquel Martinez-Garcia
    Pedro P Lopez-Casas
    Daniel Rico
    Alfonso Valencia
    Manuel Hidalgo
    Nature Medicine, 2014, 20 : 1230 - 1231
  • [3] Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
    Del Rio, Maguy
    Molina, Franck
    Mollevi, Caroline Bascoul
    Copois, Virginie
    Bibeau, Frederic
    Chalbos, Patrick
    Bareil, Corinne
    Kramar, Andrew
    Salvetat, Nicolas
    Fraslon, Caroline
    Conseiller, Emmanuel
    Granci, Virginie
    Leblanc, Benjamin
    Pau, Bernard
    Martineau, Pierre
    Ychou, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 773 - 780
  • [4] Colorectal cancer classification based on gene expression is not associated with FOLFIRI response Reply
    Sadanandam, Anguraj
    Gray, Joe
    Hanahan, Douglas
    NATURE MEDICINE, 2014, 20 (11) : 1231 - 1232
  • [5] Reply to Colorectal cancer classification based on gene expression is not associated with FOLFIRI response
    Anguraj Sadanandam
    Joe Gray
    Douglas Hanahan
    Nature Medicine, 2014, 20 : 1231 - 1232
  • [6] Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients
    Watanabe, Toshiaki
    Kobunai, Takashi
    Yamamoto, Yoko
    Matsuda, Keiji
    Ishihara, Soichiro
    Nozawa, Keijiro
    Iinuma, Hisae
    Konishi, Tsuyoshi
    Horie, Hisanaga
    Ikeuchi, Hiroki
    Eshima, Kiyoshi
    Muto, Tetsuichiro
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (06): : 419 - 425
  • [7] Gene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients
    Toshiaki Watanabe
    Takashi Kobunai
    Yoko Yamamoto
    Keiji Matsuda
    Soichiro Ishihara
    Keijiro Nozawa
    Hisae Iinuma
    Tsuyoshi Konishi
    Hisanaga Horie
    Hiroki Ikeuchi
    Kiyoshi Eshima
    Tetsuichiro Muto
    Clinical and Translational Oncology, 2011, 13 : 419 - 425
  • [8] Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal Cancer
    Pretzsch, Elise
    Peschel, Christiane A.
    Rokavec, Matjaz
    Torlot, Lucien
    Li, Pan
    Hermeking, Heiko
    Werner, Jens
    Klauschen, Frederick
    Neumann, Jens
    Jung, Andreas
    Kumbrink, Jorg
    LABORATORY INVESTIGATION, 2025, 105 (05)
  • [9] Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy
    He, Jun
    Wang, Mengyao
    Wu, Dandan
    Fu, Hao
    Shen, Xiaopei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [10] A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome
    Schell, Michael J.
    Yang, Mingli
    Missiaglia, Edoardo
    Delorenzi, Mauro
    Soneson, Charlotte
    Yue, Binglin
    Nebozhyn, Michael V.
    Loboda, Andrey
    Bloom, Gregory
    Yeatman, Timothy J.
    CLINICAL CANCER RESEARCH, 2016, 22 (03) : 734 - 745
12345